Related Experiment Videos
Cefaclor in treatment of otitis media and pharyngitis in children
Insights
Cefaclor showed promise in treating otitis media and streptococcal pharyngitis, demonstrating comparable efficacy to amoxicillin and penicillin. This antibiotic was well-tolerated with no severe adverse events reported in clinical trials.
Area of Science:
- Infectious Diseases
- Pharmacology
- Pediatrics
Background:
- Otitis media and streptococcal pharyngitis are common childhood infections.
- Antibiotic resistance necessitates ongoing evaluation of treatment options.
- Cefaclor and amoxicillin are frequently used for otitis media, while penicillin is standard for pharyngitis.
Purpose of the Study:
- To compare the safety and efficacy of cefaclor against amoxicillin trihydrate for otitis media.
- To compare the safety and efficacy of cefaclor against penicillin V potassium for streptococcal pharyngitis.
- To evaluate cefaclor's clinical outcomes and tolerability in pediatric patients.
Main Methods:
- Two single-blind controlled studies were conducted.
- 130 patients with otitis media received cefaclor or amoxicillin trihydrate.
- 88 patients with streptococcal pharyngitis received cefaclor or penicillin V potassium.
Main Results:
- Cefaclor demonstrated a trend towards fewer acute failures and better overall success in otitis media, particularly for Haemophilus influenzae infections, though not statistically significant compared to amoxicillin.
- No significant difference in clinical effectiveness was observed between cefaclor and penicillin for streptococcal pharyngitis.
- Cefaclor was well-tolerated, with no serious adverse effects reported in either study.
Conclusions:
- Cefaclor is a viable treatment option for otitis media and streptococcal pharyngitis, showing comparable efficacy to established antibiotics.
- The safety profile of cefaclor is favorable, with minimal side effects observed.
- Further research may explore cefaclor's specific advantages in certain bacterial infections like H. influenzae otitis media.
Abstract:
The safety and efficacy of cefaclor were compared with amoxicillin trihydrate in the treatment of 130 cases of otitis media, and with penicillin V potassium in 88 cases of streptococcal pharyngitis in two single-blind controlled studies. Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with pharyngitis received 20 mg/kg/day of cefaclor or penicillin V potassium for ten days. Overall, patients who received cefaclor for otitis media had fewer acute failures and better total success, especially in cases caused by Haemophilus influenzae; however, the difference between cefaclor and amoxicillin was not statistically significant. There also was no significant difference between the clinical effectiveness of cefaclor and penicillin in the treatment of streptococcal pharyngitis. Cefaclor was well tolerated with no serious side effects.